Table 1.
Treatment (group) | WBC (×103/μl) | RBC (×106/μl) | HGB (g/dl) | LYMP (%) | NEUT (%) | HCT (%) | PLT (×103/μl) |
---|---|---|---|---|---|---|---|
Nonacetic | 11.32 ± 1.03 | 10.56 ± 095 | 14.51 ± 0.77 | 69.5 ± 3.33 | 7.5 ± 0.57 | 45.72 ± 4.32 | 593 ± 14.38 |
Acetic acid | 13.47 ± 0.97 | 8.87 ± 1.18 | 13.61 ± 0.89 | 57.8 ± 3.96 | 8.9 ± 1.12 | 42.4 ± 1.80 | 631 ± 20.01 |
Sulfasalazine | 12.71 ± 1.02 | 6.95 ± 0.88 | 12.92 ± 1.25 | 51.9 ± 2.96 | 6.7 ± 0.69 | 49.31 ± 2.89 | 583 ± 36.88 |
30 mg/kg CVE | 10.32 ± 1.07 | 7.46 ± 0.64 | 11.95 ± 0.86 | 61.7 ± 6.26 | 7.3 ± 0.45 | 48.66 ± 4.58 | 667 ± 20.77 |
100 mg/kg CVE | 11.61 ± 1.52 | 6.71 ± 0.67 | 12.94 ± 1.00 | 42.2±1.94∗∗ | 5.7 ± 0.46∗ | 43.12 ± 2.50 | 580 ± 17.01 |
300 mg/kg CVE | 12.14 ± 0.99 | 7.18 ± 0.68 | 13.67 ± 0.90 | 47.3 ± 2.34 | 6.2 ± 0.16∗ | 44.90 ± 1.79 | 624 ± 16.40 |